Figure S4 from T-cell Receptor Profiling of Blood to Detect Lung Cancer

Key Points

• T-cell receptor profiling effectively identifies lung cancer from blood samples, offering a potential for early diagnosis.
• The TILS-A-A2 classifier was developed specifically to distinguish lung cancer from non-cancerous conditions.
• The analysis indicates that profiling can lead to breakthrough approaches in cancer detection and management.
• Further validation of this method could enhance early diagnostic capabilities in lung cancer treatment.

Abstract